ADPAXIL(Paclitaxel)
Therapeutic class: microtubule stabilising ability
- Ovarian Cancer
- node-positive breast cancer
- Metastatic Breast Cancer
- Non-Small Cell Lung Cancer
- AIDS-related Kaposi’s sarcoma
- 30 mg , 100 mg , 260 mg & 300 mg Injection
- 20°C to 25°C (68°F to 77°F), Shelf Life: 2 Years
- As directed by physician
